Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study-Reference-Cited by-同舟云学术

Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study

Published:2014-05-15 Issue:2 Volume:26 Page:99-105
ISSN:0956-5507
Container-title:Cytopathology
language:en
Short-container-title:Cytopathology

Author:

Bellevicine C.¹,Bianco A.¹,Malapelle U.¹,De Luca C.¹,Vigliar E.¹,Cacciola N. A.²,Pallante P.²,Troncone G.¹

Affiliation:

1. Dipartimento di Salute Pubblica; Universita Federico II; Naples Italy

2. Istituto per l'Endocrinologia e l'Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Bioteconologie Mediche; Università degli Studi di Napoli “Federico II”; Naples Italy

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference25 articles.

1. EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study;Malapelle;J Clin Pathol,2012

2. EGFR mutations detection on liquid-based cytology: is microscopy still necessary?;Malapelle;J Clin Pathol,2012

3. EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients;Malapelle;Cancer Cytopathol,2013

4. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology;Lindeman;Arch Pathol Lab Med,2013

5. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer;Yu;Clin Cancer Res,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an immuno-wall device for the rapid and sensitive detection of EGFR mutations in tumor tissues resected from lung cancer patients;PLOS ONE;2020-11-16

2. Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer;Translational Lung Cancer Research;2020-06

3. Immunocytochemistry for predictive biomarker testing in lung cancer cytology;Cancer Cytopathology;2019-05

4. Immunohistochemistry-Enabled Precision Medicine;Precision Medicine in Cancer Therapy;2019

5. Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections;Virchows Archiv;2016-01-27